{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:39:25Z","timestamp":1767915565355,"version":"3.49.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,28]]},"DOI":"10.7759\/cureus.88884","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:21:05Z","timestamp":1753694465000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful Nemolizumab Treatment of Refractory Acquired Reactive Perforating Collagenosis in a Diabetic Patient"],"prefix":"10.7759","author":[{"given":"Asuka","family":"Oikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Shiiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2023.04.003","article-title":"\u03bc-opioid receptor overexpression in acquired reactive perforating collagenosis associated with IL-31","volume":"110","author":"Kawakami T","year":"2023","unstructured":"Kawakami T, Ikeda T, Yokoyama K, Dong Y. \u03bc-opioid receptor overexpression in acquired reactive perforating collagenosis associated with IL-31. J Dermatol Sci. 2023, 110:69-71. 10.1016\/j.jdermsci.2023.04.003","journal-title":"J Dermatol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llad301","article-title":"Comment on 'Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab'","volume":"49","author":"Zhang LW","year":"2024","unstructured":"Zhang LW, Wu J, Chen T. Comment on 'Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab'. Clin Exp Dermatol. 2024, 49:909-10. 10.1093\/ced\/llad301","journal-title":"Clin Exp Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1240262","article-title":"Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation","volume":"14","author":"Liu B","year":"2023","unstructured":"Liu B, Wu Y, Wu X, Zhong X, Xue R, Zhang Z. Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation. Front Immunol. 2023, 14:1240262. 10.3389\/fimmu.2023.1240262","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llad119","article-title":"Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab","volume":"48","author":"Ohmori S","year":"2023","unstructured":"Ohmori S, Sawada Y. Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab. Clin Exp Dermatol. 2023, 48:929-41. 10.1093\/ced\/llad119","journal-title":"Clin Exp Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19864","article-title":"A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab","volume":"38","author":"Yamada K","year":"2024","unstructured":"Yamada K, Baba A, Kanekura T. A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab. J Eur Acad Dermatol Venereol. 2024, 38:e750-2. 10.1111\/jdv.19864","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15647","article-title":"Clinical practice guide for the treatment of perforating dermatosis","volume":"47","author":"Kawakami T","year":"2020","unstructured":"Kawakami T, Akiyama M, Ishida-Yamamoto A, Nakano H, Mitoma C, Yoneda K, Suga Y. Clinical practice guide for the treatment of perforating dermatosis. J Dermatol. 2020, 47:1374-82. 10.1111\/1346-8138.15647","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JD9.0000000000000336","article-title":"Systematic review and meta-analysis literature-based clinical retrospective analysis of acquired reactive perforating collagenosis","author":"Hu QiJ","year":"2023","unstructured":"Hu QiJ, Chen JJ, Yao X. Systematic review and meta-analysis literature-based clinical retrospective analysis of acquired reactive perforating collagenosis. Int J Dermatol Venereol. 2023, 10.1097\/JD9.0000000000000336","journal-title":"Int J Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381016-successful-nemolizumab-treatment-of-refractory-acquired-reactive-perforating-collagenosis-in-a-diabetic-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:21:06Z","timestamp":1753694466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381016-successful-nemolizumab-treatment-of-refractory-acquired-reactive-perforating-collagenosis-in-a-diabetic-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.88884","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}